303 related articles for article (PubMed ID: 28968662)
1. Large-scale prediction of ADAR-mediated effective human A-to-I RNA editing.
Yao L; Wang H; Song Y; Dai Z; Yu H; Yin M; Wang D; Yang X; Wang J; Wang T; Cao N; Zhu J; Shen X; Song G; Zhao Y
Brief Bioinform; 2019 Jan; 20(1):102-109. PubMed ID: 28968662
[TBL] [Abstract][Full Text] [Related]
2. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
Yuting K; Ding D; Iizasa H
Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
[TBL] [Abstract][Full Text] [Related]
3. Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR).
Solomon O; Oren S; Safran M; Deshet-Unger N; Akiva P; Jacob-Hirsch J; Cesarkas K; Kabesa R; Amariglio N; Unger R; Rechavi G; Eyal E
RNA; 2013 May; 19(5):591-604. PubMed ID: 23474544
[TBL] [Abstract][Full Text] [Related]
4. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
[TBL] [Abstract][Full Text] [Related]
5. Systematic identification of edited microRNAs in the human brain.
Alon S; Mor E; Vigneault F; Church GM; Locatelli F; Galeano F; Gallo A; Shomron N; Eisenberg E
Genome Res; 2012 Aug; 22(8):1533-40. PubMed ID: 22499667
[TBL] [Abstract][Full Text] [Related]
6. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
[TBL] [Abstract][Full Text] [Related]
7. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
8. ADAR-mediated RNA editing in non-coding RNA sequences.
Yang Y; Zhou X; Jin Y
Sci China Life Sci; 2013 Oct; 56(10):944-52. PubMed ID: 24008387
[TBL] [Abstract][Full Text] [Related]
9. Adenosine deamination in human transcripts generates novel microRNA binding sites.
Borchert GM; Gilmore BL; Spengler RM; Xing Y; Lanier W; Bhattacharya D; Davidson BL
Hum Mol Genet; 2009 Dec; 18(24):4801-7. PubMed ID: 19776031
[TBL] [Abstract][Full Text] [Related]
10. Adenosine-to-inosine RNA editing.
Zinshteyn B; Nishikura K
Wiley Interdiscip Rev Syst Biol Med; 2009; 1(2):202-209. PubMed ID: 20835992
[TBL] [Abstract][Full Text] [Related]
11. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
[TBL] [Abstract][Full Text] [Related]
12. Using mouse models to unlock the secrets of non-synonymous RNA editing.
Jinnah H; Ulbricht RJ
Methods; 2019 Mar; 156():40-45. PubMed ID: 30827465
[TBL] [Abstract][Full Text] [Related]
13. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.
Kawahara Y; Zinshteyn B; Sethupathy P; Iizasa H; Hatzigeorgiou AG; Nishikura K
Science; 2007 Feb; 315(5815):1137-40. PubMed ID: 17322061
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of microRNAs by adenosine-to-inosine editing and the selective elimination of edited microRNA precursors in mouse oocytes and preimplantation embryos.
García-López J; Hourcade Jde D; Del Mazo J
Nucleic Acids Res; 2013 May; 41(10):5483-93. PubMed ID: 23571754
[TBL] [Abstract][Full Text] [Related]
15. Adenosine to Inosine editing frequency controlled by splicing efficiency.
Licht K; Kapoor U; Mayrhofer E; Jantsch MF
Nucleic Acids Res; 2016 Jul; 44(13):6398-408. PubMed ID: 27112566
[TBL] [Abstract][Full Text] [Related]
16. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
17. ADAR2 A-->I editing: site selectivity and editing efficiency are separate events.
Källman AM; Sahlin M; Ohman M
Nucleic Acids Res; 2003 Aug; 31(16):4874-81. PubMed ID: 12907730
[TBL] [Abstract][Full Text] [Related]
18. Dynamic regulation of RNA editing in human brain development and disease.
Hwang T; Park CK; Leung AK; Gao Y; Hyde TM; Kleinman JE; Rajpurohit A; Tao R; Shin JH; Weinberger DR
Nat Neurosci; 2016 Aug; 19(8):1093-9. PubMed ID: 27348216
[TBL] [Abstract][Full Text] [Related]
19. Detection of canonical A-to-G editing events at 3' UTRs and microRNA target sites in human lungs using next-generation sequencing.
Soundararajan R; Stearns TM; Griswold AL; Mehta A; Czachor A; Fukumoto J; Lockey RF; King BL; Kolliputi N
Oncotarget; 2015 Nov; 6(34):35726-36. PubMed ID: 26486088
[TBL] [Abstract][Full Text] [Related]
20. Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.
Stellos K; Gatsiou A; Stamatelopoulos K; Perisic Matic L; John D; Lunella FF; Jaé N; Rossbach O; Amrhein C; Sigala F; Boon RA; Fürtig B; Manavski Y; You X; Uchida S; Keller T; Boeckel JN; Franco-Cereceda A; Maegdefessel L; Chen W; Schwalbe H; Bindereif A; Eriksson P; Hedin U; Zeiher AM; Dimmeler S
Nat Med; 2016 Oct; 22(10):1140-1150. PubMed ID: 27595325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
